Isoimmunization against human chorionic gonadotropin with conjugates of processed beta-subunit of the hormone and tetanus toxoid.
The immunogenicity of the conjugate prepared from "processed" beta-subunit of human chorionic gonadotropin (choriogonadotropin, HCG) and tetanus toxoid has been studied in animals and a human subject. The conjugate elicited the formation of high-affinity (Ka = 10(9)-10(11) M-1) anti-HCG and anti-tetanus antibodies. On primary immunization, the antibody, response lasted for several months. Repeat injection of the conjugate in the declining phase of antibody titers produced a booster response without a lag period. The antibodies reacted with the beta-subunit of HCG and the complete HCG molecule but were devois of significant crossreactivity with human growth hormone, placental lactogen, follicle-stimulating hormone, thyroid-stimulating hormone, and luteinizing hormone at tonic and surge levels. The antibodies were competent for neutralizing the biological activity of HCG in the mouse uterine weight gain assay, the ventral prostate weight gain assay, and the radioligand assay for binding of 125I-labeled HCG to receptors on corpus luteum. HCG (5000 international units) administered to an immunized subject was completely bound by circulating antibodies. Administration of HCG (in contrast to conjugate) was without booster effect on anti-HCG titers.
D000818:Animals; D000917:Antibody Formation; D000937:Antigen-Antibody Reactions; D002352:Carrier Proteins / Q000276:immunology; D006063:Chorionic Gonadotropin / Q000276:immunology* / Q000378:metabolism; D003429:Cross Reactions; D006041:Goats; D000882:Haplorhini; D006801:Humans; D007518:Isoantibodies / Q000096:biosynthesis*; D007519:Isoantigens / Q000633:toxicity; D008657:Metabolic Clearance Rate; D013745:Tetanus Toxoid; D013997:Time Factors
D002352:Carrier Proteins; D006063:Chorionic Gonadotropin; D007518:Isoantibodies; D007519:Isoantigens; D013745:Tetanus Toxoid